Clinical Trial: Study on the protective mechanism and clinical intervention biomarkers of neonatal intestinal flora homeostasis against necrotizing enterocolitis (NEC) in premature infants through the cross-generational transmission regulation of pathogenic bacteria-specific IgG (China)

China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the protective mechanism and clinical intervention biomarkers of neonatal intestinal flora homeostasis against necrotizing enterocolitis (NEC) in premature infants through the cross-generational transmission regulation of pathogenic bacteria-specific IgG'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135750

Registration Time: 2026/11/02

Type: Observational study

Primary Sponsor: Chongqing Health Center for Women and Children

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348333

Published by HT Digital Content Services with permission from He...